Document is current
Any future updates will be listed below
-
Authors
Badenes-Bonet, Diana
Cejudo, Pilar
Rodó-Pin, Anna
Martín-Ontiyuelo, Clara
Chalela, Roberto
Rodríguez-Portal, Jose Antonio
Vázquez-Sánchez, Rosa
Gea, Joaquim
Duran, Xavier
Caguana, Oswaldo Antonio
Rodriguez-Chiaradia, Diego Agustín
Balcells, Eva
-
Funding
Funding for this research was provided by:
rio hortega
Sociedad Española de Neumología y Cirugía Torácica
- License Information
-
More Information
Article History
Received: 19 August 2021
Accepted: 21 October 2021
First Online: 8 November 2021
Declarations
:
: This study protocol was reviewed and approved by the local ethics committee CEIC-PSMar, Barcelona, Spain with approval number 2017/7397/I, carried out according to the principles of the Declaration of Helsinki for human investigations and registered as a clinical trial (NCT04564664). All participants signed the appropriate informed consent prior to their inclusion.
: Not applicable.
: DBB has received honoraria for a speaker role from Roche, RCH has received honoraria for a speaker role from GlaxoSmithKline, Teva, Chiesi and Boehringer Ingelheim. DARC has consultant relationship with Janssen, GlaxoSmithKline, Viforpharma, MSD, Ferrer and Chiesi and has received honoraria for a speaker role from Bayer Healthcare. EBV has received honoraria for a speaker role from ROCHE and Boehringer Ingelheim. OAC has received honoraria for a speaker role from Astra Zeneca and Boehringer Ingelheim. All the conflicts of interest are not related to the submitted manuscript.
